Jaw surgery breakthrough: common drug may eliminate need for dangerous anesthesia technique
NCT ID NCT05474027
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving tranexamic acid (TXA) during jaw surgery can reduce the need for deliberate hypotensive anesthesia (DHA), a technique that lowers blood pressure to control bleeding but carries risks like stroke or kidney injury. Researchers studied 115 patients to see if TXA alone could keep the surgical field clear and blood loss low. The goal is to make surgery safer by avoiding DHA when possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD LOSS, SURGICAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UAB Hospital-Highlands
Birmingham, Alabama, 35205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A drug that may curb bleeding during fibroid surgery faces its first big test
- Which drug cuts C-Section bleeding best? tranexamic acid vs misoprostol put to the test
- Anesthesia choice may influence blood loss in hip fracture surgery
- Can a simple drug cut blood loss in kids with CP after hip surgery?
- Nose surgery blood pressure study aims to protect kidneys
- Could a single drug replace the standard cocktail for C-Section bleeding?